摘要
目的：观察β1受体阻滞剂在慢性阻塞性肺疾病合并慢性心力衰竭的疗效。方法：选取我院呼吸内科在2012年1月～2013年9月50例收住的慢性阻塞性肺疾病（COPD）合并心力衰竭患者随机分为对照组和治疗组。对照组仅给予常规治疗，治疗组除给予常规治疗外，应用美托洛尔片。分别观察2组患者的3个月内入院率及心肺功能改善情况。结果：治疗组与对照组比较，3个月内再入院率明显减低、心功能明显改善，有显著性差异（P〈0．05），对肺功能改变不明显（P〉0．05）。结论：β1受体阻滞剂在慢性阻塞性肺疾病合并慢性心力衰竭中，显著改善心力衰竭患者心功能，同时不影响肺功能。
Objective： To observe the beta 1 receptor blockers in the curative effect of chronic obstructive pulmonary disease with chro- nic heart failure. Methods：To select our hospital respiratory medicine in January 2012 to September 2013, 50 cases of chronic obstructive pulmonary disease （COPD） in our hospital combined with heart failure were randomly divided into control group and treatment group. The control group was only given routine therapy, the treatment group in addition to the given routine therapy, application of metoprolol. Re- spectively to observe the two groups of patients admitted to hospital within three months of rate and improve cardiopulmonary function. Re- sults ： The treatment group compared with control group, three months readmission rate obviously to reduce, cardiac function improved sig- nificantly, with significant difference （ P 〈 0.05 ）, the change of lung function is not obvious （ P 〉 0.05 ）. Conclusion： Beta 1 receptor blockers in chronic obstructive pulmonary disease with chronic heart failure, could significantly improve cardiac function in patients with heart failure, do not affect lung function at the same time.
出处
《中国伤残医学》
2013年第12期33-34,共2页
Chinese Journal of Trauma and Disability Medicine
关键词
慢性阻塞性肺疾病
慢性心力衰竭
β1
受体阻滞剂
Chronic obstructive pulmonary disease
Chronic heart failure
Beta 1 receptor blockers
